Announcement
·
06 May 2025
·
M42 appoints Dimitris Moulavasilis as Group CEO

Role of CROS in Driving Precision Clinical Trials in the Region to Drive Healthcare Value

31 January 2024
Healthcare Innovations and Visionaries

About the Speakers

  • Islam Eltantawy
    General Director for IROS

    Watch Next